Retinopathy of prematurity and oxygen therapy: A changing relationship;Retinopatía de la prematuridad y oxigenoterapia: Una relación cambiante

Anales de Pediatria

Volumn 62, Issue 1, 2005, Pages 48-63

  Sola, A ^a   Chow, L ^a   Rogido, M ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL OXYGEN TENSION; CLINICAL PRACTICE; DISEASE SEVERITY; OXYGEN SATURATION; OXYGEN TENSION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PULSE OXIMETRY; RETROLENTAL FIBROPLASIA; REVIEW; TRANSCUTANEOUS OXYGEN MONITORING;

EID: 14644440495     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13070182     Document Type: Article

References (96)

1. Cole CH, Wright KW, Phelps DL. Commentary: Resolving our uncertainty about oxygen therapy. Pediatrics 2003;112:1415-9.
2. Silverman WA. A Cautionary tale about supplemental oxygen. Pediatrics 2004;113:394-6.
3. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: A clinical approach. Med J Australia 1951;2:48-50.
4. Kinsey VE. Etiology of retrolental fibroplasia and preliminary report of the Cooperative Study of Retrolental Fibroplasia. Tr Am Acad Oph Otol 1955;59:15-24.
5. 2 levels and retrolental fibroplasia: a report of the Cooperative Study. Pediatrics 1977;60:655-68.
6. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992;326:1050-4.
7. Tin W, Milligan WA, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and out come at one year in babies of less than 28 weeks gestation. Arc Dis Childh F & N Ed 2001;84:F106-10.
8. Chow LC, Wright KW, Sola A, for the CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003;111:339-45.
9. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-4.
10. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-96.
11. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-9.
12. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000;105:295-310.
13. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003;349:959-67.
14. Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol 2004;24:164-8.
15. 2 levels and clinical outcome in ELBW infants on supplemental oxygen. Pediatr Res 2002;51:350A.
16. Comroe JH Jr. Retrospectroscope. Insights into Medical Discovery. Menlo Park: Von Gehr Press, California. (How to Delay Progress Without Even Trying, 1977; p. 114-9.)
17. Priestley J. Experiments and Observations on different kinds of air. Vol. II, London: Johnson, 1775. Disponible en: http:// www.mtsinai.org/pulmonary/ papers/ox-hist/ox-histl.html (Read August 2004).
18. Howell M, Ford P. The paradoxes of a small American disaster. En: The Beetle of Aphrodite. New York: Random House, 1985 (Chaussier 1780, Ylppo 1917, Flagg, 1928).
19. Silverman WA. Retrolental fibroplasia: a modern parable. New York: Grune and Startton, 1980. Disponible en: http://www. neonatology.org/classics/parable/ default.html.
20. Cross KW. Cost of preventing retrolental fibroplasia? Lancet 1973;2:954-6.
21. Bolton DPG, Cross KW. Further observations on the cost of preventing retrolental fibroplasia. Lancet 1974;1:445-8.
22. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet 1997;350:12-4.
23. Leon A, Rogido M, Sola A. Blood gas analysis: almost 80 years of fascinating history behind a two minute critical test. Pediatr Res 2003;53:303A.
24. Saugstad OD. Is oxygen more toxic than currently believed? Pediatrics 2001;108:1203-5.
25. Silverman WA. Negative discovery. Paed Perinat Epidemiol 2002:16:192-3.
26. Silverman WA. The unresolved Oxygen-level issue: Hijacked by anti-trialists. J Perinatol 2004;24:109-11.
27. Tin W. Oxygen therapy: 50 years of uncertainty. Pediatrics 2002;110:615-6.
28. Cuculich PS, DeLozier KA, Mellen BG, Shenai JP. Postnatal dexamethasone treatment and retinopathy of prematurity in very-low-birth-weight neonates. Biol Neonate 2001;79:9-14.
29. Ramanathan R, Siassi B, De Lemos RA. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. J Perinatol 1995;15:178-82; quiz 183-4.
30. Kothadia J, O'Shea TM, Grey Weaver R, Dillard RG. Retinopathy of prematurity in very preterm infants treated with dexamethasone or placebo in a randomized control trial. Pediatric Res 1997;41:201A.
31. Haroon Parupia MF, Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatol 2001;21:242-7.
32. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, Van Heuven WA, Fielder AR. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 1998;28;338:1572-6.
33. Mittal M, Dhanireddy R, Higgins RD. Candida sepsis and association with retinopathy of prematurity. Pediatrics 1998;101:654-7.
34. Noyola DE, Bohra L, Paysee EA, Fernández M, Coats DK. Association of candidemia and retinopathy of prematurity in very low birth weight infants. Ophthalmotogy 2002;109:80-4.
35. Tadesse M, Dhanireddy R, Mittal M, Higgins RD. Race, Candida sepsis, and retinopathy of prematurity. Biol Neonate 2002;81:86-90.
36. Brooks SE, Marcus DM, Gillis D, Pirie E, Johnson MH, Bhatia J. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Pediatrics 1999;104:514-8.
37. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion. Iron load and retinopathy of prematurity. Eur J Pediatr 1997;156:465-70.
38. Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 2001;62:57-63.
39. Brown M, Baron AE, France EK, Hamman RF. Association between Recombinat Human Eryhtropietin exposure and increased risk for Retinopathy of Prematurity. Pediatr Res 2003;53:303A.
40. Liu A, Dunbar J, Niemeyer M, Fayard D, Leng C, Leng J, et al. Recombinat Human EPO treatment and Incidence of Retinopathy of Prematurity. Pediatr Res 2004;55:531A.
41. Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead RE, et al. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics 2000;106:998-1005.
42. Bouzas L, Bauer G, Novali L, Dilger A, Falbo J, Díaz González L, et al. Why is retinopathy of prematurity the most frequent cause for neonatal admissions in a large NICU referral center of Argentina? Pediatr Res 2004: Abstract.
43. Benítez T, Sepúlveda C, Lomuto G, Bauer L, Galina L, Bouzas A, et al. Severe retinopathy of prematurity in argentina, a national survey of recent incidence and neonatal care practices. Pediatr Res 2004;55:531A.
44. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996;114:1219-28.
45. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Nat Acad Sci USA 2001;98:5804-8.
46. Lee EW, Grant DS, Movafagh S, Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 2003;24:99-106.
47. Koulu M, Movafagh S, Tuohimaa J, Jaakkola U, Kallio J, Pesonen U, et al. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med 2004;36:232-40.
48. Movafagh S, Geng Y, Zukowska-Grojec Z, Higgins RD. Improvement in oxygen induced retinopathy in NPY Y2 Receptor knockout mice. Pediatr Res 2003;53:303A.
49. Ju WK, Kim KY, Neufeld AH. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp Eye Res 2003;77:137-45.
50. Neufeld MD, Williams MA, Gleason CA. A specific elevated Cytokine profile is associated with development of severe retinopathy in very low birth weight infants. Pediatr Res 2003;53:423A.
51. Holmes JM, Zhang S, Leske DA, Lanier WL. Carbon dioxide-induced retinopathy in the neonatal rat. Curr Eye Res 1998;17:608-16.
52. Checchin D, Sennlaub F, Bauchamp MH, Ribeiro-da-Silva A, Chemtob S. Hypercapnia inhibits intra-retinal angiogenesis via an NO dependent pathway: Implications in Retinopathy of Prematurity. Pediatr Res 2003;53:423A.
53. Checchin D, Sennlaub F, Bauchamp MH, Gobeil F, Joya JS, Chemtob S. Mechanisms for involvement of hypercapnia in retinopathy of prematurity: A NO dependent pathway. Pediatr Res 2004;55:531A.
54. Leske DA, Wu J, Fautsch MP, Karger RA, Berdahl JP, Lanier WL, et al. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP. Molecular Vision 2004;10:43-50.
55. Gellen B, McIntosh N, McColm JR, Fleck BW. Is the partial pressure of carbon dioxide in the blood related to the development of retinopathy of prematurity? Br J Ophthalmol 2001;85:1044-5.
56. 2. Tokai J Exp Clin Med 1987;12:39-42.
57. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 2004;18:130-4.
58. O'Connor MT, Vohr BR, Tucker R, Cashore W. Is retinopathy of prematurity increasing among infants less than 1250 g birth weight? J Perinatol 2003;23:673-8.
59. Hameed B, Shyamanur K, Kotecha S, Manktelow BN, Woodruff G, Draper ES, et al. Trends in the incidence of severe retinopathy of prematurity ina a geographically defined population over a 10 year period. Pediatrics 2004;103:1653-7.
60. Larsson E, Carle-Petrelius B, Cernerud G, Ots L, Wallin A, Holmstrom G. Incidence in ROP in two consecutive Swedish population based studies. R J Ophthalmol 2002;86:1122-6.
61. Crosse VM. The problem of retrolental fibroplasia in the City of Birmingham. Tr Oph Soc U K 1951;71:609-12.
62. Patz A, Hoeck LE, De la Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I nursery observations. Am j Ophthalmol 1952;35:1248-53.
63. Kinsey VE, Jacobus JT, Hemphill F. Retrolental fibroplasias: cooperative study of retrolental fibroplasias and the use of oxygen. Arch Ophthalmol 1956;56:481-543.
64. Bedrossian R, Ritter A. Effect of oxygen weaning in retrolental fibroplasia. Arch Ophthalmol 1955;53:514-8.
65. Vento M, Asensi M, Sastre J, García-Sala F, Pallardo FV, Vina J, et al. Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics 2001;107:642-7.
66. Vento M, Asensi M, Sastre J, García-Sala F, Vina J. Six years of experience with the use of room air for the resuscitation of asphyxiated newly born term infants. Biol Neonate 2001;79:261-7.
67. Vento M, Asensi M, Sastre J, Lloret A, García-Sala F, Minana JB, et al. Hyperoxemia caused by resuscitation with pure oxygen may alter intracellular redox status by increasing oxidized glutathione in asphyxiated newly born infants. Semin Perinatol 2002;26:406-10.
68. Saugstad OD, Rootwelt T, Aalen O. Resuscitation of asphyxiated newborn infants with room air or oxygen: an international controlled trial: the Resair 2 study. Pediatrics 1998;102:1.
69. Saugstad OD. Resuscitation of newborn infants with room air or oxygen. Semin Neonatol 2001;6:233-9.
70. Saugstad OD, Ramji S, Irani SF, El-Meneza S, Hernández EA, Vento M, et al. Resuscitation of newborn infants with 21% or 100% oxygen: follow-up at 18 to 24 months. Pediatrics 2003;112:296-300.
71. Saugstad OD. Oxygen toxicity at birth: the pieces are put together. Pediatr Res 2003;54:789.
72. Saugstad OD. Optimal oxygen therapy in the Newborn Period. Pediatric Pulmonol 2004;S26:112-3.
73. Sola A, Chow L, Rogido MR. Oximetría de Pulso en Medicina Neonatal en el 2005. An Pediatr (Barc) 2005;62(3). En prensa.
74. Shiao SU. Functional versus fractional oxygen saturation readings: bias and agreement using simulated solutions and adult blood. Biol Res Nuts 2002;3:210-21.
75. Sola A, Gregory GA. Delivery Room Emergencies and Resuscitation. En: Rudolph Textbook of Pediatrics. Philadelphia: Williams and Wilkins, 2002.
76. Richards D, Poets CF, Neale S, Stebbnes VA, Alexander JR, Southall DP. Arterial oxygen saturation in preterm neonates without respiratory failure. J Pediatr 1993;123:963-968.
77. Ng A, Sibhedar N, Primhak RA, Shawa NJ. Arterial oxygen saturation profiles in healthy preterm infants. Arch Dis Child Fetal Neonatal 1998;79:F64-F6.
78. O'Brien LM, Stebbens VA, Poets CF, Heycok EG, Southall DP. Oxygen saturation during the first 24 hours of life. Arch Dis Child Fetal Neonatal 2000;83:F35-F8.
79. Moya M, Moya PR, Quesada A, Sola A. Does elective cesarean section alter postnatal pulmonary adaptation and oxygenation? Pediatr Res 2004;55:7A.
80. Bohnhorst B, Peter CS, Poets CF. Detection of hyperoxaemia in neonates: data from three new pulse oximeters. Arch Dis Child Fetal Neonatal 2002;87:F217-9.
81. Pediatrics AAP. Guidelines for Perinatal Care. 5th ed: American Academy of Pediatrics, and The American College of Obstetricians and Gynecologists; 2002.
82. Marlow N. High or low oxygen saturation for the preterm baby. Arch Dis Child Fetal Neonatal 2001;84:F149-F50.
83. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22:269-85.
84. Cnattingius S, Zack MM, Ekbom A. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Canc Inst 1995;21:908-14.
85. Penn JS, Henry MM, Tolman BL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res 1994;36:724-31.
86. Penn JS, Henry MM, Tolman BL. Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci 1994;35:3429-35.
87. Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 1995;36:2063-70.
88. Saito Y, Omoto T, Cho Y, Hatsukawa Y, Fujimura M, Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol 1993;231:151-6.
89. Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995;346:1464-5.
90. York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol 2004;24:82-7.
91. McColm JR, Cunningham S, Wade J, Sedowofia K, Gellen B, Sharma T, et al. Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res 2004;55:107-13.
92. Results of the "AVIOX" study. "Late Breaker Abstract". Presented by J. Hagadorn at the National PAS/SPR Annual Meeting, San Francisco, Ca. May 2004.
93. Yoon HZ, Yan Y, Geng Y, Higgins RD. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy. Clin Experiment Ophthalmol 2002;30:424-9.
94. Higgins RD, Yan Y, Schrier BK. Somatostatin analogs inhibit neonatal retinal neovascularization. Exp Eye Res 2002;74:553-9.
95. Sharma J, Barr SM, Geng Y, Yun Y, Higgins RD. Ibuprofen improves oxygen-induced retinopathy in a mouse model. Curr Eye Res 2003;27:309-14.
96. Yoon HZ, Yan Y, Geng Y, Higgins RD, Zasloff M, Williams JI. Regression of retinopathy by squalamine in a mouse model. Pediatr Res 2004;56:144-9.